Zhonghong Pulin Medical Products Co., Ltd. (SHE:300981)
China · Delayed Price · Currency is CNY 13.08
-0.13 (-0.98%)
At close: Feb 13, 2026
SHE:300981 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 2,445 | 2,420 | 2,068 | 1,564 | 4,901 | 4,770 |
Other Revenue | 37.08 | 37.08 | 37.59 | 8.88 | 8.76 | 8.5 |
| 2,482 | 2,457 | 2,105 | 1,573 | 4,909 | 4,778 | |
Revenue Growth (YoY) | 5.09% | 16.69% | 33.87% | -67.97% | 2.74% | 308.13% |
Cost of Revenue | 2,264 | 2,183 | 2,007 | 1,554 | 2,026 | 1,398 |
Gross Profit | 217.67 | 273.83 | 98.31 | 18.85 | 2,883 | 3,380 |
Selling, General & Admin | 242.48 | 242.37 | 219.06 | 133.55 | 116.2 | 63.68 |
Research & Development | 51.34 | 49.7 | 31.61 | 8.83 | 21.79 | 11.65 |
Other Operating Expenses | 32.05 | 14.86 | 18.42 | 18.66 | 52.96 | 36.36 |
Operating Expenses | 331.4 | 311.65 | 272.5 | 164.53 | 189.78 | 113.56 |
Operating Income | -113.73 | -37.82 | -174.19 | -145.67 | 2,693 | 3,267 |
Interest Expense | -27.76 | -24.09 | -15.35 | -1.66 | -1.61 | -10.28 |
Interest & Investment Income | 61.61 | 78.87 | 67.47 | 42.94 | 39.56 | 6.15 |
Currency Exchange Gain (Loss) | 30.07 | 30.07 | 9.57 | 35.72 | -23.98 | -83.84 |
Other Non Operating Income (Expenses) | 10.79 | -2.12 | -6.01 | -4.45 | -2.46 | -2.65 |
EBT Excluding Unusual Items | -39.02 | 44.91 | -118.52 | -73.12 | 2,705 | 3,176 |
Impairment of Goodwill | -145.85 | -145.85 | -71.89 | - | - | - |
Gain (Loss) on Sale of Investments | 37.11 | 48.11 | 60.19 | 51.46 | 61.34 | 2.43 |
Gain (Loss) on Sale of Assets | -0.07 | 0.8 | -0.09 | -0.21 | 3.18 | -0.06 |
Asset Writedown | -12.28 | -29.72 | -27.08 | -11.48 | -18.38 | -0.07 |
Other Unusual Items | 21.69 | 14.86 | 19.71 | 84.62 | 33.37 | 13.74 |
Pretax Income | -138.41 | -66.9 | -137.67 | 51.27 | 2,784 | 3,192 |
Income Tax Expense | 11.96 | 18.93 | -10 | -15.71 | 442.38 | 528.41 |
Earnings From Continuing Operations | -150.38 | -85.83 | -127.67 | 66.98 | 2,342 | 2,664 |
Minority Interest in Earnings | 5.01 | -1.3 | -3.2 | -0.07 | - | - |
Net Income | -145.37 | -87.13 | -130.87 | 66.92 | 2,342 | 2,664 |
Net Income to Common | -145.37 | -87.13 | -130.87 | 66.92 | 2,342 | 2,664 |
Net Income Growth | - | - | - | -97.14% | -12.07% | 2883.80% |
Shares Outstanding (Basic) | 435 | 436 | 423 | 433 | 393 | 322 |
Shares Outstanding (Diluted) | 435 | 436 | 423 | 433 | 393 | 322 |
Shares Change (YoY) | 2.70% | 2.89% | -2.24% | 10.19% | 22.18% | -0.60% |
EPS (Basic) | -0.33 | -0.20 | -0.31 | 0.15 | 5.96 | 8.28 |
EPS (Diluted) | -0.33 | -0.20 | -0.31 | 0.15 | 5.96 | 8.28 |
EPS Growth | - | - | - | -97.41% | -28.03% | 2901.78% |
Free Cash Flow | -80.87 | 76.51 | -61.46 | -100.95 | 1,384 | 2,290 |
Free Cash Flow Per Share | -0.19 | 0.18 | -0.14 | -0.23 | 3.52 | 7.12 |
Dividend Per Share | 0.227 | 0.227 | 0.455 | 0.489 | 1.748 | 1.554 |
Dividend Growth | -49.99% | -49.99% | -7.15% | -72.00% | 12.50% | 566.67% |
Gross Margin | 8.77% | 11.15% | 4.67% | 1.20% | 58.73% | 70.74% |
Operating Margin | -4.58% | -1.54% | -8.27% | -9.26% | 54.86% | 68.36% |
Profit Margin | -5.86% | -3.55% | -6.22% | 4.25% | 47.70% | 55.74% |
Free Cash Flow Margin | -3.26% | 3.11% | -2.92% | -6.42% | 28.19% | 47.93% |
EBITDA | 107.49 | 174.24 | 25.66 | -1.69 | 2,772 | 3,326 |
EBITDA Margin | 4.33% | 7.09% | 1.22% | -0.11% | 56.46% | 69.61% |
D&A For EBITDA | 221.22 | 212.06 | 199.84 | 143.98 | 78.68 | 59.66 |
EBIT | -113.73 | -37.82 | -174.19 | -145.67 | 2,693 | 3,267 |
EBIT Margin | -4.58% | -1.54% | -8.27% | -9.26% | 54.86% | 68.36% |
Effective Tax Rate | - | - | - | - | 15.89% | 16.55% |
Revenue as Reported | 2,482 | 2,457 | 2,105 | 1,573 | 4,909 | 4,778 |
Advertising Expenses | - | 12.05 | 8.78 | 4.86 | 5.49 | 0.87 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.